Lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

ABSTRACT:

Background

Results from the second CONCORD study (CONCORD-2) indicated that 5-year net survival for lung cancer was low (range, 10%-20%) between 1995 and 2009 in most countries, including the United States, which was at the higher end of this range.

Methods

Data from CONCORD-2 were used to analyze net survival among patients with lung cancer (aged 15-99 years) who were diagnosed in 37 states covering 80% of the US population. Survival was corrected for background mortality using state-specific and race-specific life tables and age-standardized using International Cancer Survival Standard weights. Net survival was estimated for patients diagnosed between 2001 and 2003 and between 2004 and 2009 at 1, 3, and 5 years after diagnosis by race (all races, black, and white); Surveil

SUBMITTER: Richards TB 

PROVIDER: S-EPMC5812722 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature